A Safety Study of Carfilzomib in Patients With Previously-Treated Systemic Light Chain Amyloidosis
Clinical trial NCT01789242 · COMPLETED
Trial details
- NCT number
- NCT01789242
- Sponsor
- Criterium, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2016-12-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.